213 related articles for article (PubMed ID: 33640422)
1. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H
JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743
[TBL] [Abstract][Full Text] [Related]
4. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.
Gore EM; Bae K; Wong SJ; Sun A; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
J Clin Oncol; 2011 Jan; 29(3):272-8. PubMed ID: 21135270
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer.
Ouyang W; Yu J; Zhou Y; Hu J; Huang Z; Zhang J; Xie C
BMC Cancer; 2020 Jul; 20(1):699. PubMed ID: 32723319
[TBL] [Abstract][Full Text] [Related]
6. [Present role of prophylactic cranial irradiation].
Le Péchoux C; Al Mohkles H; Dhermain F
Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
[TBL] [Abstract][Full Text] [Related]
7. Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
Balasubramanian SK; Sharma M; Venur VA; Schmitt P; Kotecha R; Chao ST; Suh JH; Angelov L; Mohammadi AM; Vogelbaum MA; Barnett GH; Jia X; Pennell NA; Ahluwalia MS
Neuro Oncol; 2020 Feb; 22(2):267-277. PubMed ID: 31648302
[TBL] [Abstract][Full Text] [Related]
8. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM
J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357
[TBL] [Abstract][Full Text] [Related]
11. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL
Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822
[TBL] [Abstract][Full Text] [Related]
12. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
[TBL] [Abstract][Full Text] [Related]
13. Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis.
Li M; Wang T; Wen P; Wang X; Wu C
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e18-e26. PubMed ID: 32761788
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer.
Sun DS; Hu LK; Cai Y; Li XM; Ye L; Hou HY; Wang CH; Jiang YH
Asian Pac J Cancer Prev; 2014; 15(3):1233-9. PubMed ID: 24606446
[TBL] [Abstract][Full Text] [Related]
15. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
[TBL] [Abstract][Full Text] [Related]
16. Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
Sharma S; McMillan MT; Doucette A; Cohen RB; Berman A; Levin W; Simone CB; Shabason J
Clin Lung Cancer; 2018 May; 19(3):260-269.e3. PubMed ID: 29358031
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis.
Xie SS; Li M; Zhou CC; Song XL; Wang CH
PLoS One; 2014; 9(7):e103431. PubMed ID: 25072281
[TBL] [Abstract][Full Text] [Related]
18. Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases.
Miyawaki E; Kenmotsu H; Mori K; Harada H; Mitsuya K; Mamesaya N; Kawamura T; Kobayashi H; Nakashima K; Omori S; Wakuda K; Ono A; Naito T; Murakami H; Endo M; Nakasu Y; Gon Y; Takahashi T
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):604-613. PubMed ID: 30851347
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients.
Yavuz AA; Topkan E; Onal C; Yavuz MN
J Exp Clin Cancer Res; 2008 Dec; 27(1):80. PubMed ID: 19055787
[TBL] [Abstract][Full Text] [Related]
20. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937.
Gore EM; Hu C; Sun AY; Grimm DF; Ramalingam SS; Dunlap NE; Higgins KA; Werner-Wasik M; Allen AM; Iyengar P; Videtic GMM; Hales RK; McGarry RC; Urbanic JJ; Pu AT; Johnstone CA; Stieber VW; Paulus R; Bradley JD
J Thorac Oncol; 2017 Oct; 12(10):1561-1570. PubMed ID: 28648948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
